Vivos Therapeutics, Inc. (VVOS)
2.19
+0.03
(+1.39%)
USD |
NASDAQ |
Dec 10, 16:00
2.27
+0.08
(+3.65%)
After-Hours: 17:28
Vivos Therapeutics EPS Diluted (Quarterly): -0.4925 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.40M |
| Revenue (Quarterly) | 6.783M |
| Total Expenses (Quarterly) | 12.18M |
| Enterprise Value | 28.83M |
| Gross Profit Margin (Quarterly) | 52.38% |
| Profit Margin (Quarterly) | -79.61% |
| Earnings Yield | -90.12% |
| Normalized Earnings Yield | -90.12 |